technology

Investors

Investors

Alder is a clinical-stage biopharmaceutical company that discovers, develops, and seeks to commercialize therapeutic antibodies with the potential to transform current treatment paradigms in meaningful ways. The work being done at Alder today will potentially help those who suffer from migraine, autoimmune diseases, and inflammatory diseases.